Thrombopoietin in thrombocytopenias of childhood

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 3, 2001, Pages 215-228

  Dame, C ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

c mpl; Children; Thrombocytopenia; Thrombopoietin; Thrombopoietin regulation

Indexed keywords

RECOMBINANT THROMBOPOIETIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR;

APLASTIC ANEMIA; BERNARD SOULIER DISEASE; CHILD; CHILDHOOD DISEASE; CONFERENCE PAPER; FANCONI ANEMIA; HEPATOBLASTOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; MEGAKARYOPOIESIS; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RADIUS APLASIA; SEPSIS; SHWACHMAN SYNDROME; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; TREATMENT INDICATION; WISKOTT ALDRICH SYNDROME;

CHILD; HEMATOPOIESIS; HUMANS; MEGAKARYOCYTES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 0034967432     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15251     Document Type: Conference Paper

References (118)

1. Blood. Thrombopoietin - At last
2. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
3. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
4. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl
5. Molecular cloning and chromosomal localization of the human thrombopoietin gene
6. Demonstration and some properties of human thrombopoietin in thrombocythaemic sera
7. Megakaryocyte morphogenesis stimulated in vitro by whole and partially fractionated thrombocytopenic plasma: A model system for the study of platelet formation
8. Megakaryocytes in states of altered platelet production: Cell numbers, size and DNA content
9. A four-step procedure for the purification of thrombopoietin
10. Partial purification and biochemical characterization of human plasma thrombopoietin
11. MPLV: A retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice
12. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors
13. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily
14. Purification and characterization of thrombopoietin
15. The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production
16. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine
17. Immunogenicity of thrombopoietin mimetic peptide GW395058 in BALB/c mice and New Zealand white rabbits: Evaluation of the potential for thrombopoietin neutralizing antibody production in man
18. Ph1-positive CML associated with megakaryocytic hyperplasia and thrombocythemia and an abnormality of chromosome no. 3
19. Acute leukemia with abnormal thrombopoiesis and inversions of chromosome 3
20. The biological significance of truncated and full-length forms of mpl ligand
21. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin
22. Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role of platelets
23. Functional analysis of the C-terminal region of recombinant human thrombopoietin. C-terminal region of thrombopoietin is a "shuttle" peptide to help secretion
24. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development
25. Expression of the thrombopoietin gene in human fetal and neonatal tissues
26. Erythropoietin mRNA expression in human fetal and neonatal tissue
27. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization
28. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets
29. Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: Evidence of thrombopoietin as a growth factor for liver endothelial cells
30. Expression of the c-mpl proto-oncogene in human hematologic malignancies
31. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia
32. Effect of thrombopoietin on proliferation of blasts from patients with myelodysplastic syndromes
33. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells
34. Use of thrombopoietic growth factors in acute leukemia
35. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood
36. Circulating hematopoietic progenitor cells in first trimester fetal blood
37. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies
38. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies
39. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies
40. Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin
41. Quantitative and qualitative differences in thrombopoietin-dependent hematopoietic progenitor development between cord blood and bone marrow
42. Thrombopoietin: The primary regulator of platelet production
43. + cells
44. Thrombopoietin mimetic peptide (GW395058) is a potent stimulant of neonatal megakaryocyte colony production
45. Role of c-mpl in early hematopoiesis
46. Thrombopoietin suppresses apoptosis and behaves as a survival factor for the human growth factor-dependent cell line, M07e
47. Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: Potential mechanisms for survival enhancing effects
48. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy
49. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia
50. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice
51. Thrombopoietin has a differentiative effect on late-stage human erythropoiesis
52. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit
53. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets
54. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platetets during thrombocytopenia and thrombocytosis
55. Hematopoietic deficiencies in c-mpl and TPO knockout mice
56. Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers
57. Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B
58. The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells
59. The essential cells of the hemopoietic microenvironment
60. Thrombopoietin levels in cord blood plasma and amniotic fluid in fetuses with alloimmune thrombocytopenia and healthy controls
61. Regulation der thrombopoiese dutch thrombopoietin and interleukin-11 bei neugeborenen mit einer praepartal bestehenden thrombozytopenie
62. Thrombopoietin concentration in umbilical cord blood of healthy term newborns is higher than in adult controls
63. Thrombopoietin in the thrombocytopenic term and preterm newborn
64. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit
65. Age-related changes in thrombopoietin in children: Reference interval for serum thrombopoietin levels
66. Stressful delivery influences circulating thrombopoietin (TPO) levels in newborns: Possible role for cortisol in TPO-mpl binding
67. Thrombopoietin levels in HIV-associated thrombocytopenia in children
68. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: Elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin
69. Haemostatic failure in babies with rhesus isoimmunization
70. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease
71. Fetal platetet counts correlate with the severity of the anemia in red-cell alloimmunization
72. Fetal liver dysfunction in Rh alloimmunization
73. Circulating thrombopoietin levels in a neonate with osteopetrosis
74. In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia
75. Circulating thrombopoietin levels in neonates with infection
76. Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis
77. Severe perinatal liver disease and Down syndrome: An apparent relationship
78. Hematological changes in Down's syndrome
79. Thrombopoietin level is inversely related to blast count, not platelet number, in Down syndrome neonates with transient myeloprotiferative disorder
80. Thrombocytopenia with absent radii syndrome: Studies on serum thrombopoietin levels and megakaryopoiesis in vitro
81. Thrombocytopenia with absent radii: Frequency of marrow megakaryocyte progenitors, proliferative characteristics, and megakaryocyte growth and development factor responsiveness
82. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome
83. Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR)
84. Thrombocytopenia with absent radii. A review of 100 cases
85. Congenital amegakaryocytic thrombocytopenia: An intrinsic hematopoietic stem cell defect
86. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia
87. C-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia
88. Mutations in the thrombopoietin receptor, mpl, in children with congenital amegakaryocytic thrombocytopenia
89. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia
90. Molecular biology of Fanconi anemia: Implications for diagnosis and therapy
91. Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias
92. Thrombopoietin level in young patients is related to megakaryocyte frequency and platelet count
93. Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment
94. Wiskott-Aldrich syndrome: Qualitative platelet defects and short platelet survival
95. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: Long-term follow-up of 62 cases
96. Wiskott-Aldrich syndrome
97. WASP is involved in proliferation and differentiation of human haemopoietic progenitors in vitro
98. Bernard-Soulier syndrome: Quantitative characterization of megakaryocytes and platelets by flow cytometric and platelet kinetic measurements
99. Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone-marrow stromal cells
100. Measurement of endogenous plasma thrombopoietin in patients with acquired aplastic anaemia by a sensitive enzyme-linked immunosorbent assay
101. Plasma thrombopoietin levels in thrombocytopenic states: Implication for a regulatory role of bone marrow megakaryocytes
102. The effect of steroid and intravenous immunoglobulin on thrombopoietin levels in pediatric patients with immune thrombocytopenic purpura
103. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction
104. Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy
105. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients
106. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood
107. Thrombopoietin in patients with hepatoblastoma
108. Serum thrombopoietin levels in Kawasaki disease
109. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease
110. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L
111. Analysis of thrombopoietin and c-mpl expression in a child with essential thrombocythemia
112. Thrombopoietin
113. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer
114. Future directions with platelet growth factors
115. Characterization of an anti-thrombopoietin antibody that developed in a cancer patient following the injection of PEG-rHuMGDF
116. The appearance of antithrombopoietin antibody and circulating thrombopoietin-IgG complexes in a patient developing thrombocytopenia after injection of PEG-rHuMGDF
117. Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys
118. Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin